Last updated: April 25, 2026
Who Supplies Clobetasol Propionate for Pharmaceutical Manufacturing?
Clobetasol propionate is supplied through two main channels: (1) finished-dose drug products and (2) active pharmaceutical ingredient (API) manufacturing and API procurement. The supplier landscape depends on whether the target is API or finished formulations (cream, ointment, lotion, spray). Without product form, country, or regulatory target specified, the only defensible approach is to map the supplier categories and the types of companies that supply clobetasol propionate at scale.
What supplier types provide clobetasol propionate?
-
API manufacturers (global, scale)
- Companies that produce clobetasol propionate API for generic and branded dermatology programs.
- Typical arrangements: DMF-supported supply, multi-site manufacturing, and commercial supply contracts.
-
API distributors and brokers (procurement channel)
- Firms that source API from one or more manufacturers and sell to formulators under defined quality documentation (COA, traceability, sometimes CEP/DMF linkage).
- Typical arrangements: short lead times, multi-source redundancy, and procurement management.
-
Finished-dose manufacturers (formulations)
- Manufacturers producing clobetasol propionate creams, ointments, and lotions (often 0.05% strength).
- Typical arrangements: contract manufacturing (CMO) for branded generics and private label.
-
Intermediate and chemical suppliers (upstream)
- Suppliers of key intermediates used in clobetasol propionate synthesis.
- Typical arrangements: earlier-stage procurement for vertically integrated API programs.
Which companies and databases reliably list clobetasol propionate suppliers?
For actionable supplier identification, the industry relies on registration and dossier databases rather than informal lists. The most widely used sources are:
- US FDA Drugs@FDA / Orange Book: shows approved products and applicants/label holders for clobetasol propionate dosage forms, which typically ties to manufacturer relationships.
- FDA DMF public disclosures and access pathways: identifies API dossier holders and some manufacturing sites linked to DMFs (where publicly accessible).
- European Medicines Agency (EMA) product listings: supports EU authorization mapping for branded and generic dermatology products, linking to marketing authorization holders.
- CEP databases (where applicable): confirm pharmaceutical substance quality documentation tied to suppliers for certain jurisdictions.
- Commercial API catalogs (subject to update cadence): supplier listings with grade, packaging, and documentation signals, but these should be validated against DMF/CEP/COA records.
What product forms are typically supplied for clobetasol propionate?
Clobetasol propionate is supplied commercially primarily as dermatologic formulations at the 0.05% strength. Supplier expectations vary by form:
- Cream (topical)
- Ointment (topical)
- Lotion (topical)
- Scalp formulations (where regionally marketed)
API suppliers must support:
- Sterility status: not sterile for topical clobetasol propionate, but quality specs include microbial limits and solvent residue controls as applicable.
- Impurity profile controls: clobetasol propionate has defined related-substance targets and thresholds in pharmacopeial and regulatory specs.
- Polymorph/solid-state: supplier controls depend on final dossier requirements.
How to identify the actual supplier behind a given clobetasol propionate product?
For procurement, the supplier question resolves by tracing who markets and who manufactures the approved product in target jurisdictions.
Best-practice evidence trail:
- Pull the specific strength and dosage form in target market (US, EU, UK, etc.).
- Extract the application holder/labeler from regulatory listings (Orange Book / national approvals).
- Identify the manufacturer or site listed on product labeling or submission summaries.
- Map that manufacturer to API sourcing through DMF linkage (where publicly visible) or by documented QA agreements and audits.
This approach is the fastest route to real supplier confirmation because marketing authorization holders and their contract manufacturing partners are often directly disclosed in regulatory artifacts.
Supplier short-listing framework (actionable for procurement and R&D)
A practical supplier shortlist for clobetasol propionate should be built on four attributes:
| Attribute |
Evidence to require |
Why it matters for clobetasol propionate |
| Regulatory dossier linkage |
DMF/CEP linkage where applicable |
Ensures defensible identity, impurity controls, and consistent quality |
| Manufacturing footprint |
Multi-site capability, batch history |
Reduces supply risk for generic dermatology launches |
| Documentation package |
COA format, specification sheet, traceability |
Validates consistency with planned stability and release testing |
| Quality system |
GMP certification and audit readiness |
Topical APIs/formulations are quality-driven and audit-sensitive |
Key Takeaways
- Clobetasol propionate supply comes from API manufacturers, distributors, and finished-dose manufacturers; procurement accuracy depends on whether you need API or finished product.
- Regulatory mapping (Orange Book / EMA listings / DMF pathways) is the most reliable method to identify the real supplier behind specific marketed strengths and forms.
- Build supplier selection around dossier linkage, manufacturing footprint, documentation, and GMP/audit readiness.
FAQs
1) Are clobetasol propionate suppliers different for API versus finished products?
Yes. API procurement targets GMP API manufacturers and dossier holders, while finished-dose sourcing targets formulation CMOs or finished-goods manufacturers.
2) What topical strength is most commonly supplied for clobetasol propionate?
Clobetasol propionate is widely marketed at 0.05% for dermatologic use, and supplier availability typically centers on that strength.
3) What documentation should procurement request for clobetasol propionate API?
At minimum: specification sheet, COA, impurity/related substance profile details, and traceability. If you operate dossier-based procurement, request DMF/CEP linkage where applicable.
4) How do I find the manufacturer behind an approved clobetasol propionate product?
Use regulatory databases to identify the application holder/labeler and the manufacturing site tied to the approved dosage form, then map that to API sourcing via DMF linkages or documented supplier audits.
5) Does clobetasol propionate require sterile manufacturing?
Topical clobetasol propionate products are typically not sterile. Supplier GMP and quality controls focus on identity, impurities, microbiological limits, and stability-critical parameters.
References
[1] U.S. Food and Drug Administration. Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[3] U.S. Food and Drug Administration. Drug Master File (DMF) information and DMF-related resources. https://www.fda.gov/drugs/drug-master-files-dmfs
[4] European Medicines Agency. Medicines. https://www.ema.europa.eu/en/medicines
